Kleemann D
Hals-Nasen-Ohren-Klinik und Poliklinik, Otto Körner, Medizinische Fakultät, Universität Rostock.
Laryngorhinootologie. 1993 Aug;72(8):402-5. doi: 10.1055/s-2007-997925.
Whereas stimulating effects of androgenic hormones on the laryngeal mucosa and their tumours have been reported in the literature, we are faced with the highest incidence of laryngeal carcinomas in the presence of a reduced androgen signal from the testes associated with aging. The discrepancies between reports in the literature and our own recent experiences with in vitro application of testosterone on permanent laryngeal squamous carcinoma cell lines, initiated this current examination of testosterone, dihydrotestosterone (DHT) and cyproterone acetate effects on two different laryngeal cancer cell lines. No DHT and cyproterone acetate effects on the androgen receptor negative line UM-SCC11B were found. However, growth of the HEp-2 line was significantly inhibited undergoing the cyproterone acetate application and significantly enhanced after DHT application. Both lines underwent a dose-dependent growth inhibition after testosterone application. These effects seem to be cytostatic rather than cytotoxic. The mechanisms leading to these effects can only be discussed hypothetically at present. Furthermore, if one takes into consideration the decrease of serum testosterone levels in aging males and the near normal levels of DHT in serum and tissues, so one may assume an imbalance between testosterone and DHT as an important cofactor in the genesis of laryngeal cancer. Current research knowledge on the basics of benign prostate hyperplasia, several experimental and clinical reports in the ENT literature together with our own experimental results, are leading to a new and hopeful therapeutic opportunity for the future, involving the blocking of 5 alpha reductase as the enzyme which manages the DHT formation from testosterone.(ABSTRACT TRUNCATED AT 250 WORDS)
尽管文献中报道了雄激素对喉黏膜及其肿瘤有刺激作用,但在与衰老相关的睾丸雄激素信号降低的情况下,我们却面临着喉癌的最高发病率。文献报道与我们最近在体外将睾酮应用于永久性喉鳞状癌细胞系的经验之间的差异,引发了本次对睾酮、双氢睾酮(DHT)和醋酸环丙孕酮对两种不同喉癌细胞系影响的研究。未发现DHT和醋酸环丙孕酮对雄激素受体阴性的UM-SCC11B细胞系有影响。然而,应用醋酸环丙孕酮后HEp-2细胞系的生长受到显著抑制,而应用DHT后则显著增强。应用睾酮后,两种细胞系均出现剂量依赖性生长抑制。这些作用似乎是细胞抑制性的而非细胞毒性的。目前只能对导致这些作用的机制进行假设性讨论。此外,如果考虑到老年男性血清睾酮水平的下降以及血清和组织中DHT水平接近正常,那么可以假设睾酮和DHT之间的失衡是喉癌发生的一个重要辅助因素。目前关于良性前列腺增生基础的研究知识、耳鼻喉科文献中的一些实验和临床报告以及我们自己的实验结果,为未来带来了一个新的且充满希望的治疗机会,即通过阻断5α还原酶(该酶负责将睾酮转化为DHT)来治疗。(摘要截取自250字)